84 related articles for article (PubMed ID: 24115038)
1. Anti-lymphangiogenesis effects of a specific anti-interleukin 7 receptor antibody in lung cancer model in vivo.
Jian M; Qingfu Z; Yanduo J; Guocheng J; Xueshan Q
Mol Carcinog; 2015 Feb; 54(2):148-55. PubMed ID: 24115038
[TBL] [Abstract][Full Text] [Related]
2. [Interleukin 7 and its receptor promote cell proliferation and induce lymphangiogenesis in non-small cell lung cancer].
Ming J; Zhang QF; Jiang YD; Jiang GC; Qiu XS
Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):511-8. PubMed ID: 23157741
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: a mechanism of lymphangiogenesis in lung cancer.
Ming J; Zhang Q; Qiu X; Wang E
Eur J Cancer; 2009 Mar; 45(5):866-73. PubMed ID: 19136250
[TBL] [Abstract][Full Text] [Related]
4. The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells.
Al-Rawi MA; Watkins G; Mansel RE; Jiang WG
Int J Oncol; 2005 Sep; 27(3):721-30. PubMed ID: 16077922
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 7 upregulates vascular endothelial growth factor D in breast cancer cells and induces lymphangiogenesis in vivo.
Al-Rawi MA; Watkins G; Mansel RE; Jiang WG
Br J Surg; 2005 Mar; 92(3):305-10. PubMed ID: 15672426
[TBL] [Abstract][Full Text] [Related]
6. Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer: Enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells.
Chen X; Xie Q; Cheng X; Diao X; Cheng Y; Liu J; Xie W; Chen Z; Zhu B
Cancer Sci; 2010 Nov; 101(11):2384-90. PubMed ID: 20825419
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-7 up-regulates cyclin D1 via activator protein-1 to promote proliferation of cell in lung cancer.
Ming J; Jiang G; Zhang Q; Qiu X; Wang E
Cancer Immunol Immunother; 2012 Jan; 61(1):79-88. PubMed ID: 21847632
[TBL] [Abstract][Full Text] [Related]
9. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
[TBL] [Abstract][Full Text] [Related]
10. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
11. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
12. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
13. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
14. COX-2-mediated regulation of VEGF-C in association with lymphangiogenesis and lymph node metastasis in lung cancer.
Liu H; Yang Y; Xiao J; Lv Y; Liu Y; Yang H; Zhao L
Anat Rec (Hoboken); 2010 Nov; 293(11):1838-46. PubMed ID: 20830783
[TBL] [Abstract][Full Text] [Related]
15. Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation.
Watari K; Nakao S; Fotovati A; Basaki Y; Hosoi F; Bereczky B; Higuchi R; Miyamoto T; Kuwano M; Ono M
Biochem Biophys Res Commun; 2008 Dec; 377(3):826-31. PubMed ID: 18951870
[TBL] [Abstract][Full Text] [Related]
16. Potential implication of IL-24 in lymphangiogenesis of human breast cancer.
Frewer NC; Ye L; Sun PH; Owen S; Ji K; Frewer KA; Hargest R; Jiang WG
Int J Mol Med; 2013 May; 31(5):1097-104. PubMed ID: 23546515
[TBL] [Abstract][Full Text] [Related]
17. Effect of local hyperthermia on lymphangiogenic factors VEGF-C and -D in a nude mouse xenograft model of tongue squamous cell carcinoma.
Liang X; Zhou H; Liu X; He Y; Tang Y; Zhu G; Zheng M; Yang J
Oral Oncol; 2010 Feb; 46(2):111-5. PubMed ID: 20036606
[TBL] [Abstract][Full Text] [Related]
18. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract][Full Text] [Related]
19. [Effects on lymphangiogenesis and angiogenesis of lung cancer with antisense oligonucleotides of vascular endothelial growth factor C].
Guo XF; Xu ZH; Chen YB; Xu ZH; Yang WT; Qian YY; Hu GQ
Zhonghua Wai Ke Za Zhi; 2008 May; 46(9):694-6. PubMed ID: 18956726
[TBL] [Abstract][Full Text] [Related]
20. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]